Evolving or immutable – phase I solid tumor trials in the era of precision oncology
Investigational New Drugs – In the era of precision oncology (PO), systemic therapies for patients (pts) with solid tumors have shifted from chemotherapy (CT) to targeted therapy (TT) and…